Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
128
NCT04331132
Tolvaptan add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction
Phase: N/A
Role: Collaborator
Start: Dec 1, 2021
Completion: Jul 26, 2023